When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ARDS - Aridis Pharm enrolls first COVID-19 patient in late-stage AR-301 trial
Aridis Pharmaceuticals Inc.
Aridis Pharmaceuticals (NASDAQ:ARDS) enrolls first COVID-19 patient in its ongoing Phase 3 clinical trial of AR-301, a monoclonal antibody against S. aureus induced pneumonia in patients who were already on mechanical ventilators.
More news on: Aridis Pharmaceuticals, Inc., Healthcare stocks news,